| SESSION |
|
Registration Opens
Networking
|
|
Local Innovation Spotlight
Moderator: Joe Siok
Featured Presenters
1. AIVA – Stan Holt
2. APN Health – David Krum
3. Endotronix - Harry Rowland
4. PhysIQ – Gary Conkright
Panel Discussion
|
Morning Keynote
When Cardiologists Play Video Games, Everybody Wins
Level Ex shares how video game technology and design is transforming physician education
Sam Glassenberg, LEVEL EX, Founder & CEO
|
| Lunch/Networking |
Welcome Address
Michael Davidson, MD, Professor, Director of the Lipid Clinic, The University of Chicago Pritzker School of Medicine
|
Keynote Address
Making Cardiovascular Outcome Trials Cost Effective
Rob Califf, MD, Vice Chancellor for Health Data Science, Duke University |
Session 1: The Challenges of a CV Biotech Startup
Moderator: James Liao, MD, Chief Division of Cardiology, The University of Chicago
Medical Center
1. Daniel Bloomfield, MD, Chief Executive Officer, Cardurion Pharmaceuticals
2. Marc Semigran, MD, Chief Medical Officer, MyoKardia Inc.
3. Rahul Kakkar, MD, Chief Medical Officer, Chief Strategy Officer, Corvidia Therapeutics
4. Panel Discussion |
Session 2: Improving Clinical Trials
Moderator: TBD
1. Abhinav Sharma, MD, Stanford – Insights from the startup perspective
2. Panel Discussion |
| Networking Break |
Session 3: Venture Capital: What factors improve investment decisions regarding CV therapies
Moderators: Michael Davidson, MD Professor, Director of the Lipid Clinic, The University of Chicago Pritzker School of Medicine AND Lee Shapiro, Managing Partner, 7Wire Ventures
1. Karim Helmy, PhD, Vice President, Venrock Ventures
2. Aaron Kantoff, Principal, Apple Tree Ventures
3. Ari Brettman, Principal, Clarus Ventures
4. Panel Discussion |
Session 4: Pharmaceuticals: The Future of R&D Investment in CV
Moderator: Clyde Yancy, MD, Vice Dean for Diversity and Inclusion, Chief of Cardiology, Department of Medicine, Northwestern
• Björk, Elisabeth, VP Late Clinical Development, AstraZeneca
• Boehringer Ingelheim, Thomas Seck, MD Senior Vice President, Medicine and Regulatory Affairs
• Jay Edelberg, MD, PhD – Vice President, Head Cardiovascular Development, Sanofi
• Ed Cinca – NovoNordisk – Vice President GLP-1 Portfolio
• Dr. Aarif Khakoo, Vice President Medical Science, Amgen |
| Networking Break |
Session 5: The Role of the FDA in the facilitation of CV therapeutic Development
Moderator: Michael Davidson, MD & Clyde Yancy, MD
• Norman Stockbridge, MD, PhD, Director of the Division of Cardiovascular and Renal Products, FDA Center for Drug Evaluation and Research
• Aliza Thompson, MD, Medical Officer (Team Leader), FDA
• Matthew Hillebrenner, Supervisory Biomedical Engineer, FDA
• Panel Discussion |
Panel 6: Payors: Understanding the Payor’s Perspective on CV Drug Reimbursement
Moderator: TBD
• Cigna
• HCSC
• TBD
• Panel Discussion |
| Closing Remarks: Michael Davidson, MD |
| Cocktail Reception |
